About 30,000 Trademarks found for “parker institute for cancer immunotherapy”

Providing personal support services for families of patients with life threatening disorders, namely, companionship, help with medical forms, emotional counseling, and emotional support

"IMMUNOTHERAPY"

"CANCER IMMUNOTHERAPIES"

Providing a website featuring information to patients and healthcare providers relating to oncological and autoimmune disorders

[ Medical services ]

Pharmaceutical products [ in the nature of chemicals ] for cancer treatment, oncology and immunotherapy; [ sanitary preparations for medical purposes; ] pharmaceutical products for human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy [ for auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Substances for medicinal use, namely, synthetic peptides for cancer treatment, oncology and immunotherapy, adjuvants for medical purposes, stem cells for medical purposes; Vaccines for treating cancer; vaccines; Substances for medicinal use, namely, serums for cancer treatment, oncology and immunotherapy, monoclonal antibodies for cancers, auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, targeted therapies for cancers, auto immune diseases and biological tissue grafts or skin grafts ]

MEDICAL SERVICES, NAMELY, HUMAN CANCER TREATMENT INVOLVING THE ADMINISTRATION OF ACTIVATED PATIENT T-CELLS

Computer application software for personal computers, namely, software for allergy practices and patients to assist and supplement patient care

Pharmaceutical preparations comprising antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases; Pharmaceutical preparations comprising immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases

"IMMUNOTHERAPEUTICS"

Medicines for humans and animals, vaccines, serums for medical purposes, and diagnostic preparations for medical purposes for treating cancer, in particular manufactured using molecular biological, genetic engineering and biotechnological methods; test kits for principally comprised of diagnostic preparations for medical purposes that contains at least one of soluble t-cell receptors, and genetically modified cells for determining the type and existence of a tumour in a patient, in particular manufactured using molecular biological, genetic engineering and biotechnological methods; proteins and cells, namely, immune cells carrying a target specific effector protein, protein conjugates, peptides, enzymes and enzyme preparations, in particular antibodies and t-cell proteins, all for medical purposes; t-cells, dendritic cells other immune system cells, and viruses, all for medical purposes;plant extracts for medical purposes; medicines, vaccines, adjuvants, serums all for immunotherapy and the treatment of benign and malignant tumours, haematological tumours, inflammatory disorders, neurodegenerative disorders, and autoimmune conditions in particular manufactured using molecular biological, genetic engineering and biotechnological methods; test kits and diagnostic agents comprised of medical diagnostic preparations that contain at least one of soluble t-cell receptors and genetically modified cells for the diagnosis of benign and malignant tumours, haematological tumours, inflammatory disorders, neurodegenerative disorders, and autoimmune conditions in particular manufactured using molecular biological, genetic engineering and biotechnological methods

MEDI GENE IMMUNOTHERAPY'S

Printed publications, namely, peer-reviewed medical magazines, journals, newsletters, feature reports, monographs, and printed supplements to the foregoing in the fields of immunology, hematology, oncology and cancer

The mark consists of a stylized light blue and blue orb with a stylized light blue tree on it, white shading on the top right portion, the orb being contained within two stylized blue leaves. To the right of the orb is the upper case blue wording "EMINDES CANCER," underneath which is the title case dark gray wording "ONCOLOGICAL IMMUNOTHERAPY."